Cerebral Edema and Cerebral Hemorrhages in Interleukin-10-Deficient Mice Infected with Plasmodium chabaudi

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 3054-3058

  Sanni, Latifu A ^a,b   Jarra, William ^a   Li, Ching ^a,c   Langhorne, Jean ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; BRAIN EDEMA; CEREBRAL HEMORRHAGE; FEMALE; INTERLEUKIN-10; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM CHABAUDI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142711618     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.3054-3058.2004     Document Type: Article

References (23)

1. Brown, H., S. Rogerson, T. Taylor, M. Tembo, J. Mwenechanya, M. E. Molyneux, and G. Turner. 2001. Blood-brain barrier function in cerebral malaria in Malawian children. Am. J. Trop. Med. Hyg. 64:207-213.
2. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212.
3. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated over-production of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86:5572-5574.
4. Grau, G. E., P. F. Piguet, P. Vassalli, and P. H. Lambert. 1989. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:49-70.
5. Hulier, E., P. Petour, G. Snounou, M.-P. Nivez, D. Mazier, and L. Renia. 1996. A method for the quantitative assessment of malaria parasite development in organs of the mammalian host. Mol. Biochem. Parasitol. 77:127-135.
6. Knight, J. C., I. Udalova, A. V. Hill, B. M. Greenwood, N. Peshu, K. Marsh, and D. Kwiatkowski. 1999. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22:145-150.
7. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91:536-540.
8. Kuhn, R., J. Lohler, D. Rennick, K. Krajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
9. Kurtzhals, J. A. L., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliva-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentration of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
10. Langhorne, J., S. J. Quin, and L. A. Sanni. 2002. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem. Immunol. 80:204-228.
11. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67:4435-4442.
12. Li, C., L. A. Sanni, F. Omer, E. Riley, and J. Langhorne. 2003. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor β antibodies. Infect. Immun. 71:4850-4856.
13. Linke, A., R. Kuhn, W. Muller, N. Honamar, C. Li, and J. Langhorne. 1996. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 84:253-263.
14. Maegraith, B., and A. Fletcher. 1972. The pathogenesis of mammalian malaria. Adv. Parasitol. 10:49-75.
15. Mota, M. M., W. Jarra, E. Hirst, P. K. Patnaik, and A. A. Holder. 2000. Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way. Infect. Immun. 68:4135-4144.
16. Neighbors, M., X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra. 2001. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon gamma production. J. Exp. Med. 194:343-354.
17. Othoro, C., A. A. Lal, B. Nahlen, D. Koech, A. S. S. Orago, and V. Udhayakumar. 1999. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179:279-282.
18. Rudin, W., N. Favre, G. Bordmann, and B. Ryeffel. 1997. Interferon-gamma is essential for the development of cerebral malaria. Eur. J. Immunol. 27:810-815.
19. Sanni, L. A. 2001. The role of cerebral oedema in the pathogenesis of cerebral malaria. Redox Rep. 6:137-142.
20. Sanni, L. A., S. R. Thomas, B. N. Tattam, D. E. Moore, G. Chaudhri, R. Stocker, and N. H. Hunt. 1998. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am. J. Pathol. 152:611-619.
21. Slade, S. J., and J. Langhorne. 1989. Production of interferon-gamma during infection with Plasmodium chabaudi chabaudi. Immunobiology 179:353-365.
22. Thumwood, C. M., N. H. Hunt, I. A. Clark, and W. B. Cowden. 1988. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 96:579-589.
23. Warrell, D. A., S. Looareesuwan, R. E. Phillips, N. J. White, M. J. Warrell, H. M. Chapel, S. Areekul, and S. Tharavanij. 1986. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am. J. Trop. Med. Hyg. 35:882-889.